DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation (Q41783861)
Jump to navigation
Jump to search
scientific article published on 6 April 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation |
scientific article published on 6 April 2011 |
Statements
1 reference
DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation (English)
1 reference
1 reference
Olaf Stüve
1 reference
Bao-Xi Qu
1 reference
Min Fu
1 reference
Todd N Eagar
1 reference
Roger N Rosenberg
1 reference
6 April 2011
1 reference
1 reference
867-874
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference